Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 802 results for "Treatment For Multiple Sclerosis"

Jack Osbourne on living with multiple sclerosis and overcoming depression

Actelion Using Combination Strategy to Attack Multiple Sclerosis

Actelion Ltd. is seeking more effective treatments for people suffering from multiple sclerosis by following a strategy that's worked in treating HIV, cancer and heart failure -- combining medicines to increase their potency. The company has begun ... Bloomberg, 3 days ago

95 images for Treatment For Multiple Sclerosis, 6 days ago
HCPLive, 1 week ago
PharmaVOICE, 1 month ago
CBC, 4 days ago
European Pharmaceutical Review, 5 days ago, 1 month ago
Pharmafile, 6 days ago
HCPLive, 1 month ago
HCPLive, 1 month ago
HCPLive, 1 month ago
Physicians Weekly

Multiple Sclerosis Misdiagnosis Supports Improved Education of Clinicians

Advertisement A number of common conditions are mistaken for multiple sclerosis (MS), a disabling central nervous system disease, say researchers at four academic medical centers across the U.S. in a study published online today in the journal ...
 Physicians Weekly3 days ago MS researchers hopeful about reversing some effects of the disease  Consumer Affairs1 week ago testing long term rituximab treatment in an ms clinic  HCPLive1 week ago Multiple Sclerosis Makes Patients Avoid Risks  HCPLive1 week ago

New Impetus Found for Treatment of Brain Diseases

Tumor necrosis factor (TNF) seemed a promising target twenty years ago in the treatment of brain diseases like multiple sclerosis or Alzheimer's Disease. But clinical trials produced disappointing results. Now University of Groningen scientists ...
 MedIndia1 week ago Can cannabis oil treat my weakening limbs?  HealthMediciNet.com5 days ago New impetus for treatment neurodegenerative diseases  EurekAlert!1 week ago The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review  Journal of the American Medical Association2 weeks ago

Roche's Ocrelizumab Expected To Introduce Major Shifts In The Treatment Paradigm For Multiple Sclerosis

By a News Reporter-Staff News Editor at Biotech Week -- There is high anticipation for Roche's ocrelizumab, a monoclonal antibody that was granted "Breakthrough Therapy Designation" by the FDA earlier this year for its potential indication in ...
 4 Traders2 days ago

Merck KGaA returns PhII multiple sclerosis drug to Apitope

Merck KGaA has returned a Phase II multiple sclerosis drug to Apitope. The German drugmaker picked up the rights to the peptide-based therapeutic in 2009 and advanced it to the cusp of a Phase IIa readout, but has now decided to relinquish its claim ...
 FierceBiotech6 days ago Merck KGaA Hands Back Novel Multiple Sclerosis Drug to Apitope  BioSpace6 days ago Apitope reclaims multiple sclerosis treatment from Merck after 7 years  Pharmafile6 days ago Apitope to develop MS drug, Merck KGaA tie-up ends  pharmaphorum6 days ago

Stem cell hope for MS battler

A BATTLING Oldhamer left wheelchair-bound through Multiple Sclerosis is set to travel to Mexico for pioneering treatment. Peter Barrie Wright (49) hopes the revolutionary procedure will prove so successful it will "give him his life back". Now, he ...
 Brief days ago MS sufferer goes for same treatment that proves a life line for his sister  Brief days ago

News from the Congress of ECTRIMS: Siponimod Found to Slow Disability Progression in Advanced MS

Researchers reported that fewer patients with relapsing-remitting multiple sclerosis who were treated with siponimod had disability progression at three months, compared with those taking placebo. LONDON — The number of multiple sclerosis (MS) ...
 Neurology Today2 days ago Study: Alemtuzumab Reverses Some Physical Disability in MS Patients  PT Community1 week ago which patients with ms are likely to get worse  HCPLive1 week ago Alemtuzumab in MS: Disability Reversal Possible  Diabetes Care1 week ago

Patent Application Titled "Treatment of Multiple Sclerosis with Combination of Laquinimod and Fingolimod" Published Online (USPTO 20160279118)

By a News Reporter-Staff News Editor at Diabetes Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors Hallak, Hussein (East Jerusalem, IL); Tarcic, Nora (Modiin, IL); ...
 4 Traders1 week ago Patent Application Titled "Toll-Like Receptor 4 Antagonists and Use in Autoimmune Liver Diseases" Published Online (USPTO 20160287578)  4 Traders2 days ago Patent Issued for Hydroxylated KRN7000 Analogue and Use (USPTO 9464105)  4 Traders2 days ago

Natalizumab Treatment Eases Depression in Patients With Multiple Sclerosis: Presented at ANA

You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 13 days for your content allowance to be renewed. Sign up for a free trial to ...
 FirstWord Pharma3 days ago

Powerful MS Drug Used Early May Reverse Some Disability

By Steven Reinberg HealthDay Reporter FRIDAY, Oct. 14, 2016 (HealthDay News) -- A multiple sclerosis drug usually reserved for people in the late stages of the disease seems to offer long-term remission in newly diagnosed patients, researchers ...
 US News & World Report1 week ago Insurers pay more for multiple sclerosis drug because rebates don't help, report says  StatNews.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Treatment For Multiple Sclerosis
Get updated on latest news & your favorite topics right in your inbox!
More     Less